Unknown

Dataset Information

0

Genetic influences on cognitive decline in Parkinson's disease.


ABSTRACT: The role of genetic factors in cognitive decline associated with Parkinson's disease (PD) is unclear. We examined whether variations in apolipoprotein E (APOE), microtubule-associated protein tau (MAPT), or catechol-O-methytransferase (COMT) genotypes are associated with cognitive decline in PD. We performed a prospective cohort study of 212 patients with a clinical diagnosis of PD. The primary outcome was change in Mattis Dementia Rating Scale version 2 score. Linear mixed-effects models and survival analysis were used to test for associations between genotypes and change in cognitive function over time. The ?4 allele of APOE was associated with more rapid decline (loss of 2.9; 95% confidence interval [CI]: 1.7-4.1) of more points per year; P < 0.001) in total score and an increased risk of a ? 10 point drop during the follow-up period (hazard ratio, 2.8; 95% CI: 1.4-5.4; P = 0.003). MAPT haplotype and COMT genotype were associated with measures of memory and attention, respectively, over the entire follow-up period, but not with the overall rate of cognitive decline. These results confirm and extend previously described genetic associations with cognitive decline in PD and imply that individual genes may exert effects on specific cognitive domains or at different disease stages. Carrying at least one APOE ?4 allele is associated with more rapid cognitive decline in PD, supporting the idea of a component of shared etiology between PD dementia and Alzheimer's disease. Clinically, these results suggest that genotyping can provide information about the risk of future cognitive decline for PD patients.

SUBMITTER: Morley JF 

PROVIDER: S-EPMC3323737 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic influences on cognitive decline in Parkinson's disease.

Morley James F JF   Xie Sharon X SX   Hurtig Howard I HI   Stern Matthew B MB   Colcher Amy A   Horn Stacy S   Dahodwala Nabila N   Duda John E JE   Weintraub Daniel D   Chen-Plotkin Alice S AS   Van Deerlin Vivianna V   Falcone Dana D   Siderowf Andrew A  

Movement disorders : official journal of the Movement Disorder Society 20120216 4


The role of genetic factors in cognitive decline associated with Parkinson's disease (PD) is unclear. We examined whether variations in apolipoprotein E (APOE), microtubule-associated protein tau (MAPT), or catechol-O-methytransferase (COMT) genotypes are associated with cognitive decline in PD. We performed a prospective cohort study of 212 patients with a clinical diagnosis of PD. The primary outcome was change in Mattis Dementia Rating Scale version 2 score. Linear mixed-effects models and su  ...[more]

Similar Datasets

| S-EPMC8301732 | biostudies-literature
| S-EPMC4842380 | biostudies-literature
| S-EPMC6877592 | biostudies-literature
| S-EPMC7853194 | biostudies-literature
| S-EPMC4825674 | biostudies-literature
| S-EPMC4863747 | biostudies-literature
| S-EPMC5325129 | biostudies-literature
| S-EPMC8636132 | biostudies-literature
| S-EPMC5763317 | biostudies-literature
| S-EPMC1828039 | biostudies-literature